Response

To the Editor:
We thank Dr Smith for his thoughtful comments regarding our recent publication in CHEST (October 2012). 1 We took great interest in his recently published fi ndings demonstrating an increase in estimated pulmonary artery pressures in healthy air passengers without hypoxemia. 2 In our study, we used an a priori-defi ned oxygen desaturation value of pulse oxygen saturation (Sp o 2 ) , 85% (corresponding to partial pressure of oxygen in the blood of approximately 50 mm Hg at sea level). We chose this value to maintain a high specifi c ity for oxygen desaturation events, consistent with this being the recommended threshold for prescribing in-fl ight supplemental oxygen in individuals, based on altitude simulation testing. 3 We agree that a more sensitive threshold for oxygen desaturation may correlate better with fl ight symptoms and/or pulmonary vasoconstriction events. Using our original threshold of Sp o 2 , 85%, we did not fi nd a signifi cant association between desaturation events and fl ight symptoms ( P 5 .25). However, we did fi nd that the oxygen saturation nadir was lower in individuals with fl ight symptoms compared with those without symptoms (Sp o 2 , 85% vs 89%; P 5 .03). Notably, even when using this more restrictive cutoff for Sp o 2 of 85%, there were four subjects who remained asymptomatic despite desaturation events.
Using a more sensitive threshold of oxygen desaturation (Sp o 2 , 88%), we found a signifi cant association with fl ight symptoms ( P , .01) and a similar number of individuals with asymptomatic oxygen desaturation. When the threshold was further increased (Sp o 2 , 90%) , we saw an even stronger association with fl ight symptoms, but there was also a substantial increase in the number of individuals with asymptomatic oxygen desaturation by this defi nition. Therefore, a cutpoint of Sp o 2 , 88% appeared to have the best performance characteristics with respect to reported symptoms. Dr Smith's fi ndings, taken together with our study results, imply that even under mildly hypoxic conditions, individuals with underlying pulmonary vascular disease may experience symptoms as a result of elevations in pulmonary artery pressure. 1, 4 Further studies are needed to better understand the relationship between changes in pulmonary artery pressures, symptoms, and desaturation events during fl ight, and their implications with regard to air travel safety for patients with pulmonary vascular disease. 
